Israeli company Brainsway Ltd., which develops innovative devices for treatment of mental disorders using magnetic pulses, has announced that it has received US Food and Drug Administration (FDA) approval for its Deep TMS system. The system uses transcranial magnetic stimulation (TMS) for treating depression in patients who cannot be treated using standard methods.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

AI Can Predict Future Heart Attacks By Analyzing CT Scans
October 01, 2023

Israeli Startups Create Powerful Drone-Detecting Software
September 28, 2023

Model Sees Daylight As Boost For Hospitalized Patients’ Health
September 28, 2023

Solar Panels On A Roll Certified As Safe For Use In US, Europe
September 28, 2023
Facebook comments